Related Experiment Video
Updated: May 8, 2026
Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
Published on: March 7, 2025
Use of zebrafish apoptosis assays for preclinical drug discovery
Patricia McGrath1, Wen Lin Seng
1Phylonix , 100 Inman Street, Cambridge, 02139, MA , USA pat@phylonix.com.
Introduction:
Apoptosis has become an important target for drug discovery. Although the mouse remains the animal model of choice for the preclinical assessment of drug toxicity and efficacy, zebrafish are increasingly used for early drug studies. Here, we describe approaches for assessing drug effects on apoptosis in transparent zebrafish.
Areas Covered:
In this review, the authors discuss the drug effects on developmentally regulated apoptosis using microscopy. They also discuss the effects of neuroprotectants in a chemical induced disease model using morphometric image analysis. Finally, the authors review the effects of radioprotectants in irradiated whole animals using a conventional 96-well microplate format.
Expert Opinion:
Several challenges have limited more widespread use of zebrafish as the organism of choice for drug screening. However, zebrafish do have a number of compelling inherent advantages including: rapid organogenesis, transparency, statistically significant numbers of animals per experiment and adaptability of cell-based methods.
Insights
Zebrafish offer a transparent and adaptable model for studying drug effects on apoptosis, a key target in drug discovery. These fish provide advantages for early drug screening and toxicity assessments.
Area of Science:
- Developmental Biology
- Pharmacology
- Toxicology
Background:
- Apoptosis is a critical target for novel drug discovery and development.
- While mice are standard for preclinical drug assessment, zebrafish are emerging as valuable models for early drug studies.
- Zebrafish's transparency facilitates direct observation of drug effects on apoptosis.
Purpose of the Study:
- To outline methods for assessing drug-induced apoptosis in zebrafish.
- To review the utility of zebrafish in drug discovery and toxicity screening.
Main Methods:
- Microscopy for observing drug effects on developmentally regulated apoptosis.
- Morphometric image analysis for evaluating neuroprotectants in chemically induced disease models.
- 96-well microplate format for assessing radioprotectant effects in irradiated zebrafish.
Main Results:
- The review details various approaches for drug screening in zebrafish.
- Specific methods discussed include microscopy, image analysis, and microplate assays.
Conclusions:
- Zebrafish present unique advantages for drug screening, including rapid organogenesis, transparency, and adaptability to cell-based assays.
- Despite challenges, zebrafish are a promising model for early drug discovery and toxicity evaluation.
- Their suitability for high-throughput screening is enhanced by the ability to use statistically significant numbers of animals per experiment.
